Skip to content
Denis Chem Lab logo

Denis Chem Lab

537536 BSE
Price unavailable

Denis Chem Lab (DENISCHEM) share price was ₹61.37 at the 28 Oct 2026 close; market capitalisation ₹85.20 Cr; P/E (TTM) 10.67; sector Healthcare. The share price fell 31.7% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 1.6% year on year to ₹44.0 Cr and net profit fell 17.3% year on year to ₹2.05 Cr (compared with Jun 2025). Promoters held 38.98% of Denis Chem Lab in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 58/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹61.37 −30.27 −33.03% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹85.20 Cr
P/E (TTM)
10.67
EBITDA
₹19.60 Cr
Return on Equity
9.18%
Debt to Equity
0.04
Book Value
₹65.99
EPS (TTM)
₹5.75
52W High
₹94.60
52W Low
₹56.10

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,767.6035.064,24,106 Cr5.070.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,659.0087.672,56,416 Cr15.300.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,609.6072.361,75,334 Cr9.540.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,187.10108.061,18,172 Cr22.300.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,181.0026.281,17,805 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,338.4034.661,11,714 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,362.2032.641,10,046 Cr3.110.96%11.21%14.88%28,589 Cr3,356 Cr
Denis Chem Lab (this company)
—10.6785 Cr0.934.14%9.18%13.67%185 Cr8 Cr
Median 8 companies₹1,767.6034.861,17,988 Cr4.710.72%12.98%16.41%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

58 Good
Overall score

Data confidence 100/100

Category scores

Quality Good 58
Returns, margins, earnings quality 22% weight
Valuation Strong 79
Cheap vs sector & own history 24% weight
Growth Weak 43
Sales & profit trajectory 9% weight
Financial Health Strong 75
Solvency, leverage, coverage 9% weight
Momentum Poor 25
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

4
  • Company is almost debt free.
  • Stock is trading at 1.02 times its book value
  • Stock is providing a good dividend yield of 3.70%.
  • Company has been maintaining a healthy dividend payout of 32.7%

Weaknesses

3
  • The company has delivered a poor sales growth of 10.8% over past five years.
  • Promoter holding is low: 39.0%
  • Company has a low return on equity of 11.2% over last 3 years.

Technical Indicators

Oscillators

Bearish

Bearish
3
Neutral
5
Bullish
1

Overall

Bearish

Bearish
12
Neutral
5
Bullish
2

Moving Averages

Bearish

Bearish
9
Neutral
0
Bullish
1

Growth Rate

Revenue Growth
4.5% higher than 3Y

change over 1 year

Net Income Growth
3.7% higher than 3Y

change over 1 year

Cash Flow Change
-65.84%

change over 1 year

EBITDA Margin Change
1.33%

change over 1 year Operating margin 8.7% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
42.48
45.43
40.06
39.85
41.26
47.82
42.84
41.38
43.28
46.17
45.52
46.75
44
Expenses
37.45
40.29
34.07
34.77
36.91
41.94
39.01
39.32
38.46
41.91
39.49
44.21
40.17
Operating Profit
5.03
5.14
5.99
5.08
4.35
5.88
3.83
2.06
4.82
4.26
6.03
2.54
3.83
OPM %
11.84%
11.31%
14.95%
12.75%
10.54%
12.3%
8.94%
4.98%
11.14%
9.23%
13.25%
5.43%
8.7%
Other Income
0.01
0.52
0.26
0.59
0.32
0.58
0.3
1.17
0.3
0.65
0.44
0.54
0.45
Interest
0.09
0.09
0.13
0.23
0.12
0.09
0.07
0.23
0.19
0.23
0.22
0.2
0.11
Depreciation
1.59
1.76
1.84
1.75
1.63
1.66
1.84
1.73
1.61
1.65
1.83
1.74
1.53
PBT
3.36
3.81
4.28
3.69
2.92
4.71
2.22
1.27
3.32
3.03
4.42
1.14
2.64
Tax %
20.24%
33.07%
25.23%
26.02%
28.77%
25.05%
20.72%
44.09%
25.3%
27.06%
24.66%
64.91%
22.73%
Net Profit
2.68
2.54
3.2
2.73
2.08
3.53
1.76
0.71
2.48
2.21
3.32
0.4
2.05
EPS (₹)
1.93
1.83
2.31
1.97
1.5
2.54
1.27
0.51
1.79
1.59
2.39
0.29
1.48
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
75
98
112
107
123
135
109
136
161
167
173
181
182
Expenses
66
89
98
95
110
120
99
122
142
146
157
164
166
Operating Profit
9
8
14
12
14
15
10
14
19
21
16
18
17
OPM %
12%
9%
12%
11%
11%
11%
9%
11%
12%
13%
9%
10%
9%
Other Income
0
0
1
1
2
0
0
1
1
1
2
2
2
Interest
5
7
6
5
3
3
2
1
1
1
1
1
1
Depreciation
4
6
7
6
6
7
6
6
8
7
7
7
7
PBT
0
-3
2
2
6
6
3
9
11
15
11
12
11
Tax %
78%
30%
37%
-5%
-7%
26%
27%
30%
28%
26%
27%
29%
—
Net Profit
0
-4
1
2
6
4
2
6
8
11
8
8
8
EPS (₹)
0.07
-4.16
0.89
1.54
4.58
3.03
1.63
4.51
5.66
8.04
5.82
6.06
5.75
Div. Payout %
0%
0%
0%
0%
22%
0%
46%
33%
35%
31%
26%
41%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
9
9
12
14
14
14
14
14
14
14
14
14
Reserves
8
7
18
36
43
45
48
53
58
66
71
78
Borrowings
48
44
37
25
23
14
9
3
2
1
1
4
Other Liabilities
17
24
27
26
26
25
22
27
25
28
26
29
Total Liabilities
81
85
94
101
106
97
92
96
99
109
112
125
Fixed Assets
42
40
44
40
50
46
41
42
35
38
39
37
CWIP
0
10
1
5
0
0
0
0
2
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
39
35
49
56
55
52
51
55
62
72
73
88
Total Assets
81
85
94
101
106
97
92
96
99
109
112
125
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
14
21
7
11
8
13
8
17
16
18
12
4
Investing
-28
-13
-1
-16
-2
-2
-1
-10
-11
-15
-8
-5
Financing
13
-7
0
1
-5
-14
-6
-7
-4
-4
-4
0
Net Cash Flow
-1
1
5
-4
1
-3
1
0
1
-1
0
0
Free Cash Flow
-14
8
5
2
-2
11
6
12
12
11
4
-1
CFO/OP
154
246
49
92
65
101
85
126
100
104
105
38
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
123
85
104
105
106
94
110
85
71
69
65
78
Inventory Days
40
39
35
52
50
51
60
50
39
43
37
40
Days Payable
81
119
136
150
102
108
103
99
79
90
81
81
Cash Conversion Cycle
81
4
3
8
55
37
67
36
31
22
21
36
Working Capital Days
-19
-57
-13
4
17
32
63
51
41
37
38
50
ROCE %
11%
5%
12%
9%
11%
11%
6%
14%
16%
20%
14%
14%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Denis Chem Lab insights

69 extracted metrics + investor summaries across FY11–FY27.

Shareholding Pattern

FIIs0.01%Promot.38.98%Others26.11%Public34.90%As ofSep 2026

Documents

1
Concall - Jul 2020 Jul 2020
2
Concall - Feb 2020 Feb 2020
3
Concall - Nov 2019 Nov 2019
4
Concall - Aug 2019 Aug 2019
5
Concall - May 2019 May 2019

Frequently Asked Questions about Denis Chem Lab

What does Denis Chem Lab Ltd do?
Incorporated in 1982, Denis Chem Lab Ltd does manufacturing of Pharmaceuticals Transfusion Solution in Bottles[1]
Where is Denis Chem Lab Ltd (DENISCHEM) listed?
Denis Chem Lab Ltd trades under code 537536 on the BSE.
Which sector does Denis Chem Lab Ltd belong to?
Denis Chem Lab Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Denis Chem Lab Ltd?
Denis Chem Lab Ltd has a market capitalisation of ₹85.2 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Denis Chem Lab Ltd?
Denis Chem Lab Ltd trades at a PE ratio of 10.67 as of 28 Oct 2026, on earnings per share of ₹5.75, against a book value of ₹65.99 per share.
What is the 52-week high and low of Denis Chem Lab Ltd?
Over the last 52 weeks Denis Chem Lab Ltd has traded between ₹56.1 and ₹94.6 as of 28 Oct 2026.
Does Denis Chem Lab Ltd pay dividends?
Denis Chem Lab Ltd has a dividend yield of 4.07%.
What is the Return on Equity (ROE) of Denis Chem Lab Ltd?
Denis Chem Lab Ltd reported a return on equity of 9.18%. Its debt-to-equity ratio is 0.04.

Company Information

Incorporated in 1982, Denis Chem Lab Ltd does manufacturing of Pharmaceuticals Transfusion Solution in Bottles[1]

Website denischemlab.com
Face Value ₹ 10
Shares Outstanding 1,38,83,432

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/537536.md for Denis Chem Lab Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month